Majchrzak-Celińska, A.; Sidhu, A.; Miechowicz, I.; Nowak, W.; Barciszewska, A.-M.
ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors. J. Clin. Med. 2022, 11, 5655.
https://doi.org/10.3390/jcm11195655
AMA Style
Majchrzak-Celińska A, Sidhu A, Miechowicz I, Nowak W, Barciszewska A-M.
ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors. Journal of Clinical Medicine. 2022; 11(19):5655.
https://doi.org/10.3390/jcm11195655
Chicago/Turabian Style
Majchrzak-Celińska, Aleksandra, Arvinder Sidhu, Izabela Miechowicz, Witold Nowak, and Anna-Maria Barciszewska.
2022. "ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors" Journal of Clinical Medicine 11, no. 19: 5655.
https://doi.org/10.3390/jcm11195655
APA Style
Majchrzak-Celińska, A., Sidhu, A., Miechowicz, I., Nowak, W., & Barciszewska, A.-M.
(2022). ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors. Journal of Clinical Medicine, 11(19), 5655.
https://doi.org/10.3390/jcm11195655